<?xml version="1.0" encoding="UTF-8"?>
<p>Respiratory infections due to HAdV cause significant morbidity and mortality, with case fatality rates as high as 12%.[
 <xref rid="pone.0205795.ref011" ref-type="bibr">11</xref>] There is also a risk of up to 30% of developing long-term respiratory complications such as post-infectious bronchiolitis obliterans (PIBO) and bronchiectasis. [
 <xref rid="pone.0205795.ref001" ref-type="bibr">1</xref>,
 <xref rid="pone.0205795.ref012" ref-type="bibr">12</xref>]
</p>
